Related Experiment Videos
MDR1 gene expression and its clinical relevance in primary gastric carcinomas
Background:
Drug resistance remains a major problem in gastric carcinomas. To evaluate the mechanisms involved in this resistance, the authors determined the expression of the MDR1 gene, a multidrug resistance gene, in primary gastric carcinomas.
Methods:
MDR1 RNA levels of gastric carcinoma specimens (n = 22) were determined by slot blot analysis. An MDR1 cDNA (probe 5A) was used for the hybridization.
Results:
MDR1 RNA was detected in 41% of the gastric carcinomas, with high levels in 18% of the specimens. No expression of the MDR3 gene was observed in these tumors. MDR1 gene expression was independent of patient age, tumor localization, and lymph node involvement. However, MDR1 RNA expression was less frequent in locally advanced tumors and was absent in the primary tumors of all six patients who had distant metastases.
Conclusions:
The data indicate that multidrug-resistant cells are present in primary gastric carcinomas and suggest that multidrug resistance might contribute to the clinical drug resistance of these tumors.
Insights
Multidrug resistance (MDR1) gene expression was found in 41% of gastric carcinomas, suggesting its role in clinical drug resistance. This study investigated MDR1 RNA levels in primary tumors.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Drug resistance is a significant challenge in treating gastric carcinomas.
- Understanding the mechanisms of multidrug resistance is crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the expression of the multidrug resistance gene 1 (MDR1) in primary gastric carcinomas.
- To evaluate the potential role of MDR1 in clinical drug resistance of gastric cancer.
Main Methods:
- Analysis of MDR1 RNA levels in 22 gastric carcinoma specimens using slot blot hybridization.
- Utilized an MDR1 cDNA probe (5A) for hybridization.
Main Results:
- MDR1 RNA was detected in 41% of gastric carcinomas, with 18% showing high expression levels.
- MDR1 gene expression was independent of patient age, tumor location, and lymph node status.
- MDR1 RNA expression was less frequent in advanced tumors and absent in patients with distant metastases.
Conclusions:
- Multidrug-resistant cells are present in primary gastric carcinomas.
- MDR1 gene expression may contribute to the clinical drug resistance observed in gastric cancer patients.